|
1
|
Bruemmer D and Law RE: Thiazolidinedione
regulation of smooth muscle cell proliferation. Am J Med.
115:87–92. 2003. View Article : Google Scholar
|
|
2
|
Carmody BJ, Arora S, Wakefield MC, Weber
M, Fox CJ and Sidawy AN: Progesterone inhibits human infragenicular
arterial smooth muscle cell proliferation induced by high glucose
and insulin concentrations. J Vasc Surg. 36:833–838. 2002.
View Article : Google Scholar
|
|
3
|
Cifarelli V, Luppi P, Tse HM, He J,
Piganelli J and Trucco M: Human proinsulin C-peptide reduces high
glucose-induced proliferation and NF-κB activation in vascular
smooth muscle cells. Atherosclerosis. 201:248–257. 2008.PubMed/NCBI
|
|
4
|
Isenović ER, Kedees MH, Tepavcević S,
Milosavljević T, Korićanac G, Trpković A and Marche P: Role of
PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation
of vascular smooth muscle cells proliferation. Cardiovasc Hematol
Disord Drug Targets. 9:172–180. 2009.PubMed/NCBI
|
|
5
|
Gizard F, Nomiyama T, Zhao Y, et al: The
PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell
proliferation by repressing cell cycle-dependent telomerase
activation. Circ Res. 103:1155–1163. 2008. View Article : Google Scholar
|
|
6
|
Herbert KE, Mistry Y, Hastings R, Poolman
T, Niklason L and Williams B: Angiotensin II-mediated oxidative DNA
damage accelerates cellular senescence in cultured human vascular
smooth muscle cells via telomere-dependent and independent
pathways. Circ Res. 102:201–208. 2008. View Article : Google Scholar
|
|
7
|
Jacob T, Hingorani A and Ascher E:
Evidence for telomerase activation in VSMCs exposed to
hyperglycemic and hyperhomocysteinemic conditions. Angiology.
60:562–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Serrano AL and Andrés V: Telomeres and
cardiovascular disease: does size matter? Circ Res. 94:575–584.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gancarcíková M, Zemanová Z, Brezinová J,
Berková A, Vcelíková S, Smigová J and Michalová K: The role of
telomeres and telomerase complex in haematological neoplasia: the
length of telomeres as a marker of carcinogenesis and prognosis of
disease. Prague Med Rep. 111:91–105. 2010.PubMed/NCBI
|
|
10
|
Jones CH, Pepper C and Baird DM: Telomere
dysfunction and its role in haematological cancer. Br J Haematol.
156:573–587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sprouse AA, Steding CE and Herbert BS:
Pharmaceutical regulation of telomerase and its clinical potential.
J Cell Mol Med. 16:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cesselli D, Beltrami AP, D’Aurizio F, et
al: Effects of age and heart failure on human cardiac stem cell
function. Am J Pathol. 179:349–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
El Assar M, Angulo J, Vallejo S, Peiró C,
Sánchez-Ferrer CF and Rodríguez-Mañas L: Mechanisms involved in the
aging-induced vascular dysfunction. Front Physiol.
3:1322012.PubMed/NCBI
|
|
14
|
Fyhrquist F and Saijonmaa O: Telomere
length and cardiovascular aging. Ann Med. 44(Suppl 1): S138–S142.
2012. View Article : Google Scholar
|
|
15
|
Cao Y, Li H, Mu FT, Ebisui O, Funder JW
and Liu JP: Telomerase activation causes vascular smooth muscle
cell proliferation in genetic hypertension. FASEB J. 16:96–98.
2002.PubMed/NCBI
|
|
16
|
Coppey LJ, Davidson EP, Rinehart TW,
Gellett JS, Oltman CL, Lund DD and Yorek MA: ACE inhibitor or
angiotensin II receptor antagonist attenuates diabetic neuropathy
in streptozotocin-induced diabetic rats. Diabetes. 55:341–348.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li
YJ and Fu ZW: Low dose streptozotocin (STZ) combined with high
energy intake can effectively induce type 2 diabetes through
altering the related gene expression. Asia Pac J Clin Nutr.
16(Suppl 1): 412–417. 2007.PubMed/NCBI
|
|
18
|
Wang Y, Qiao L, Qiu J, Mi W, Han Y and
Zhong C: Establishing primary cultures of vascular smooth muscle
cells from the spiral modiolar artery. Int J Pediatr
Otorhinolaryngol. 76:1082–1086. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He X, Qiao Q, Ge N, et al:
Irradiation-induced telomerase activity and gastric cancer risk: a
case-control analysis in a Chinese Han population. BMC Cancer.
10:3122010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang J, Li LS, Yang DL, Gong QH, Deng J
and Huang XN: Inhibitory effect of ginsenoside rg1 on vascular
smooth muscle cell proliferation induced by PDGF-BB is involved in
nitric oxide formation. Evid Based Complement Alternat Med.
2012:3143952012. View Article : Google Scholar
|
|
21
|
McMurray HF, Parrott DP and Bowyer DE: A
standardised method of culturing aortic explants, suitable for the
study of factors affecting the phenotypic modulation, migration and
proliferation of aortic smooth muscle cells. Atherosclerosis.
86:227–237. 1991. View Article : Google Scholar
|
|
22
|
Sun X, Han F, Yi J, Han L and Wang B:
Effect of aspirin on the expression of hepatocyte NF-kappaB and
serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J
Korean Med Sci. 26:765–770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jacob T, Clouden N, Hingorani A and Ascher
E: The effect of cotinine on telomerase activity in human vascular
smooth muscle cells. J Cardiovasc Surg (Torino). 50:345–349.
2009.PubMed/NCBI
|
|
24
|
Belair CD, Yeager TR, Lopez PM and
Reznikoff CA: Telomerase activity: a biomarker of cell
proliferation, not malignant transformation. Proc Natl Acad Sci
USA. 94:13677–13682. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matthews C, Gorenne I, Scott S, et al:
Vascular smooth muscle cells undergo telomere-based senescence in
human atherosclerosis: effects of telomerase and oxidative stress.
Circ Res. 99:156–164. 2006. View Article : Google Scholar
|
|
26
|
Chen H, Li Y and Tollefsbol TO: Strategies
targeting telomerase inhibition. Mol Biotechnol. 41:194–199. 2009.
View Article : Google Scholar : PubMed/NCBI
|
